The medications that Hims prescribes are, for the most part, FDA-approved drugs with decades of clinical data behind them. Finasteride, minoxidil, sildenafil, tadalafil, and semaglutide all went through standard regulatory review before reaching the market. The safety question with Hims is less about the pills themselves and more about how they reach you: whether an online questionnaire catches everything an in-person visit would, whether the specific formulation you receive is the same as the FDA-approved version, and whether your particular health profile makes a given drug riskier than the marketing suggests.
What Hims Actually Dispenses
Hims operates as a direct-to-consumer telehealth platform, connecting you with licensed providers who can write prescriptions after an online consultation. The platform’s most popular products fall into a few categories: finasteride and minoxidil for hair loss, sildenafil and tadalafil for erectile dysfunction, and more recently, GLP-1 receptor agonist medications for weight loss. Each of these drugs has its own FDA approval history, its own side-effect profile, and its own set of people who should not be taking it.
An important distinction that often gets lost in Hims marketing: the platform sometimes offers compounded versions of medications rather than the brand-name or standard generic. Compounded drugs are mixed by specialty pharmacies to create custom formulations. They are not individually reviewed or approved by the FDA the way manufactured generics are. A study examining direct-to-consumer websites selling compounded GLP-1 medications found that a large share of those sites referenced FDA approval in their product descriptions, blurring the line between an FDA-approved active ingredient and an FDA-approved finished product.1PubMed Central. Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado That distinction matters: a compounded version of semaglutide, for instance, uses the same molecule, but the final product has not gone through the same manufacturing and quality checks as Novo Nordisk’s Ozempic or Wegovy.
Finasteride and Sexual Side Effects
Finasteride is one of the most commonly prescribed drugs through Hims, used at a low dose to slow or reverse male pattern hair loss. It works by blocking an enzyme that converts testosterone into a more potent form called DHT, which is the hormone responsible for shrinking hair follicles in men genetically prone to baldness. The drug is FDA-approved for this use and has been on the market since the late 1990s.
The side effects that get the most attention are sexual. Erectile dysfunction, reduced sex drive, and decreased ejaculate volume have been reported in studies, with rates ranging from roughly 3 to 16 percent of men depending on the study.2PubMed Central. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review For most men, these effects resolve after stopping the drug. The more contentious question is whether a small subset of users experiences persistent sexual dysfunction that continues even after discontinuation.
This idea, sometimes called “post-finasteride syndrome,” has generated significant media coverage and online discussion. A critical review of the studies reporting prolonged sexual dysfunction and depression concluded that while these reports do raise legitimate concerns, the studies themselves carry significant bias, making it difficult to draw firm conclusions.3PubMed Central. Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring? That same systematic review found no direct causal link between finasteride and depression, though depression is listed on the medication packaging based on several small studies.2PubMed Central. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review
The honest picture is that finasteride is well-tolerated by the large majority of men who take it, but sexual side effects are real and not vanishingly rare. If you’re considering it through Hims or any other channel, the risk is worth knowing about upfront rather than discovering after you’ve been on the medication for weeks.
Minoxidil and What It Does to Your Body
Minoxidil is Hims’ other flagship hair-loss treatment, available as a topical liquid or foam and, increasingly, as a low-dose oral tablet. Unlike finasteride, it doesn’t work through hormones. It widens blood vessels in the scalp, which is thought to stimulate hair follicles and extend their growth phase. Topical minoxidil has been available over the counter for decades and has a generally mild safety profile.
The most common complaint with topical minoxidil is scalp irritation: itching, dryness, and flaking. One randomized trial found that three-quarters of patients using topical minoxidil experienced scalp itching and dryness.4PubMed. Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial That sounds alarming as a percentage, but for most people it’s a mild annoyance rather than a reason to stop treatment.
Oral minoxidil is where the safety conversation gets more interesting. Because minoxidil was originally developed as a blood pressure medication, the oral form can cause cardiovascular effects even at low doses. The same trial found headaches in about one in five patients taking oral minoxidil and dizziness in about one in seven, along with occasional ankle swelling.4PubMed. Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial A comprehensive review confirmed that cardiovascular symptoms are rarely reported with topical minoxidil but are a recognized concern with the oral version.5Skin Appendage Disorders. Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review Unwanted hair growth on the face and body, called hypertrichosis, can occur with both forms but is more common with oral minoxidil.
If Hims prescribes you oral minoxidil, you should be aware that this use is technically off-label. The FDA approved oral minoxidil only for severe high blood pressure, not for hair loss. Off-label prescribing is legal and extremely common in medicine, but it means the specific dose and indication you’re using haven’t gone through the same formal review process as, say, the topical version.
Erectile Dysfunction Drugs and the Nitrate Problem
Sildenafil (the active ingredient in Viagra) and tadalafil (Cialis) are two of Hims’ most popular products. Both are FDA-approved for erectile dysfunction and belong to a class of drugs called PDE5 inhibitors. Their safety record across large populations is reassuring. A review of 67 double-blind, placebo-controlled trials plus postmarketing surveillance data found no causal link between sildenafil and cardiovascular events, and no new safety risks related to heart problems, priapism, or hearing loss.6PubMed Central. Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database
The common side effects are predictable and typically mild: headache, flushing, nasal congestion, and sometimes indigestion. These stem from the same blood-vessel-widening mechanism that produces the intended effect. Most men tolerate them well, and they tend to lessen with repeated use.
The genuinely dangerous interaction, though, is with nitrate medications. Nitrates are prescribed for chest pain (angina) and come in forms like nitroglycerin tablets, patches, and sprays. Combining a PDE5 inhibitor with a nitrate can cause a severe, potentially life-threatening drop in blood pressure. Research on tadalafil specifically showed that when nitroglycerin was given within 24 hours of taking tadalafil, standing blood pressure dropped below safe thresholds in significantly more subjects compared with placebo.7PubMed. Time course of the interaction between tadalafil and nitrates The interaction was no longer significant at 48 hours or beyond, but the window of danger is real. This is the single most important safety check for anyone using these medications, and it’s one that an online questionnaire needs to catch reliably.
Beyond nitrates, PDE5 inhibitors can also interact with certain blood pressure medications, alpha-blockers used for prostate problems, and some antifungal or antibiotic drugs. An in-person doctor might notice you’re taking one of these by reviewing your pharmacy records or asking follow-up questions in conversation. Whether a telehealth intake form catches all of them depends entirely on how thorough the questionnaire is and how honestly you fill it out.
GLP-1 Weight Loss Medications and Gut Side Effects
Hims has entered the weight-loss market by offering GLP-1 receptor agonist medications, the same class that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). These drugs mimic a gut hormone that slows stomach emptying, reduces appetite, and helps regulate blood sugar. They produce meaningful weight loss in clinical trials, but the side effects are predominantly gastrointestinal and often front-loaded in the early weeks of treatment.
A pharmacovigilance analysis based on the FDA’s adverse event database identified over 5,400 cases of gastrointestinal problems linked to semaglutide. The rate of gut-related complaints was roughly four times higher for semaglutide than for other drugs in the overall database.8Frontiers in Public Health. Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system Nausea, vomiting, diarrhea, and constipation are the most frequently reported symptoms. The analysis also flagged 17 adverse events that were considered unexpected signals, suggesting the full side-effect picture is still emerging.
One common worry is that the weight loss from these drugs is simply a byproduct of feeling too nauseated to eat. Clinical trial data argues against that interpretation. A mediation analysis across multiple trials found that nausea and vomiting accounted for a tiny fraction of the weight loss difference between semaglutide and comparison drugs. In one trial, less than 0.1 kilograms out of nearly 4 kilograms of additional weight loss could be attributed to nausea and vomiting.9BMJ Open Diabetes Research & Care. Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events The drug works through appetite regulation and metabolic pathways, not by making you sick.
The concern specific to Hims is whether you’re getting the FDA-approved manufactured version of semaglutide or a compounded formulation. As noted earlier, compounded versions use the same active ingredient but are mixed by compounding pharmacies without the same regulatory oversight applied to commercially manufactured drugs. If Hims is offering a compounded GLP-1 product, the safety assurance you get from the original clinical trials applies to the molecule but not necessarily to the finished product in your hands.
How the Online Model Affects Your Safety
The medications themselves are well-studied, but Hims’ delivery mechanism introduces its own layer of risk. Direct-to-consumer telehealth platforms allow you to get a prescription without ever seeing a doctor in person, and often without an existing relationship with the prescribing provider. That convenience comes with trade-offs. Researchers have flagged concerns about the lack of regulation, transparency, and established patient-provider relationships in this model.10PubMed Central. Direct to Consumer Telemedicine: Is Healthcare From Home Best?
In practice, this means the safety screening depends heavily on the information you provide in an online form. If you forget to mention a medication, understate a health condition, or don’t realize a particular interaction is relevant, the prescribing provider may not catch it the way an in-person doctor might during a back-and-forth conversation. The nitrate-ED drug interaction is a perfect example: it’s life-threatening, well-known to clinicians, and entirely dependent on the patient accurately disclosing what else they take.
That said, surveys of people who have used sexual health telehealth platforms paint a largely positive picture of the experience. In one survey, about 80 percent of respondents reported that they trusted the platform to offer safe and effective care, felt the entire process from intake to prescription was medically safe, understood the risks and benefits of their medication, and believed the platform followed proper safety standards.11PubMed Central. Individual Perceptions of the Efficacy, Quality, and Safety of Sexual Health Care Delivered via a Direct-to-Consumer Telehealth Platform: Retrospective Analysis of Data From a Cross-Sectional Survey Study Patient satisfaction, of course, is not the same as clinical safety. People can feel confident about a process that still has structural gaps.
Research on direct-to-consumer advertising for prescription drugs has also found that familiarity with drug marketing increases the likelihood that someone will acquire a medication, and that certain populations are more likely to obtain medications without proper medical guidance.12Journal of Public Policy & Marketing. Direct-to-Consumer Advertising: Exposure, Behavior, and Policy Implications Platforms like Hims sit at the intersection of healthcare and marketing, and the streamlined path from ad to prescription can work against the kind of careful gatekeeping that traditionally keeps medications matched to the right patients.
Ongoing Monitoring and Follow-Up
One of the underappreciated safety questions with any telehealth platform is what happens after you start taking the medication. With a traditional doctor, follow-up visits, blood work, and check-ins are built into the prescribing relationship. Finasteride users, for example, might benefit from periodic PSA (prostate-specific antigen) monitoring since the drug affects those levels. Oral minoxidil users should have their blood pressure and heart rate tracked. People on GLP-1 drugs need monitoring for things like pancreatitis symptoms and gallbladder problems.
Telehealth in general has shown promise for long-term management. A prospective study on telemedicine for blood pressure management found that patients in the telemedicine group had significantly better blood pressure control and higher medication adherence than those in a standard care group.13PubMed Central. Assessing the long-term outcomes of telemedicine consultations in managing hypertension: A prospective study But that study involved structured, ongoing telemedicine consultations with the same providers over time, which is a different model from a one-time online questionnaire that generates a recurring prescription.
The degree to which Hims builds in follow-up care varies by product and by your engagement with the platform. Some users report receiving check-in messages; others describe a largely hands-off experience after the initial prescription. If you’re going to use a platform like this, taking ownership of your own follow-up is a reasonable hedge. That means paying attention to side effects, reporting them promptly, and seeing your regular doctor periodically if you’re on any of these medications long-term.
Regulatory Gaps in Direct-to-Prescription Platforms
The legal and regulatory framework around platforms like Hims is still catching up to the business model. Traditional pharmaceutical advertising by drug manufacturers is subject to FDA rules requiring disclosure of side effects and contraindications. Telehealth companies engaged in functionally similar promotional activity, however, may not be covered by the same requirements. Legal scholars have argued that this creates a regulatory disconnect where platforms can advertise specific medications through social media and other channels without the same disclosure obligations that apply to the drug companies themselves.14American Journal of Law & Medicine. The Professional Regulation and Ethics of Direct-to-Prescription Marketing
There are also concerns about financial entanglements. When the same company that profits from selling you a medication is also responsible for the medical consultation that decides whether you need it, the incentive structure is different from a traditional doctor’s visit. A recent legal analysis proposed prohibiting physicians from having financial ties to entities that profit from their prescribing decisions, and suggested that the False Claims Act could be used to enforce such rules.15UC Davis Law Review. Direct-to-Prescription Telehealth and the Corporatization of Medicine State licensing boards have the authority to intervene when prescribing practices become problematic, as they demonstrated during the opioid crisis, but enforcement in the telehealth space has been inconsistent.
None of this means Hims is operating outside the law. The platform uses licensed providers and licensed pharmacies. But the regulatory environment is permissive in ways that shift more of the safety burden onto you as the consumer. You’re the one who needs to disclose your full medical history accurately, flag potential drug interactions, and recognize when a side effect warrants medical attention. The platform facilitates access to real medications, but it does not replicate the full safety net of an ongoing relationship with a doctor who knows your health history.
When Hims Might Not Be the Right Fit
For a generally healthy person in their twenties or thirties who wants to try topical minoxidil or low-dose finasteride for early hair thinning, or who has straightforward erectile dysfunction with no cardiovascular history, Hims is a reasonable option. The medications are well-understood, the risks are manageable, and the convenience of the platform is a genuine advantage for people who might otherwise never address the issue at all.
The calculus changes if you have a complex medical history. People taking nitrates, alpha-blockers, or multiple blood pressure medications need a provider who can carefully evaluate drug interactions before prescribing an ED medication. Anyone with a history of heart disease, low blood pressure, or liver or kidney problems should have a more thorough evaluation than most online questionnaires provide. If you’re considering a compounded weight-loss medication, the quality control question becomes more acute, and understanding whether you’re getting the FDA-approved manufactured version or a pharmacy-mixed alternative is essential before you start injecting anything.
Mental health medications add another layer. Long-term use of certain psychiatric drugs can affect the cardiovascular system, liver, kidneys, and endocrine system.16Journal of Psychiatry Research & Reports. Long-Long-Term Side Effects of Prescription Drugs for Mental Health: An Organ Specific Analysis and Exploration of Healthy Alternatives If you’re already on an antidepressant or mood stabilizer and you add a finasteride prescription through Hims, the overlap of side effects on mood and sexual function becomes something a provider should actively manage rather than passively screen for through a form. Sexual side effects from finasteride can mimic or worsen those caused by SSRIs, and teasing apart which drug is responsible for what symptom is the kind of clinical judgment that benefits from an established doctor-patient relationship.17PubMed Central. Finasteride and sexual side effects
The broadest way to think about it: Hims is safe for straightforward cases where the main barrier to treatment was inconvenience or embarrassment, not diagnostic complexity. The further your situation drifts from straightforward, the more value you get from a provider who can do more than check boxes on a screen.